Champions Oncology, Inc.CSBRNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+3.6%
5Y CAGR+8.9%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+3.6%/yr
vs +20.0%/yr prior
5Y CAGR
+8.9%/yr
Recent deceleration
Acceleration
-16.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
2 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $32.81M | +9.3% |
| 2025 | $30.03M | +2.1% |
| 2024 | $29.40M | -0.4% |
| 2023 | $29.53M | +25.0% |
| 2022 | $23.63M | +10.2% |
| 2021 | $21.45M | +26.2% |
| 2020 | $17.00M | +19.2% |
| 2019 | $14.27M | +35.2% |
| 2018 | $10.55M | +8.8% |
| 2017 | $9.70M | - |